Latest Acutaas Chemicals stock price

Acutaas Chemicals P/E Ratio

ACUTAAS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
88.56
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 88.56
Current Price ₹1763.20
EPS (TTM) ₹19.91
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 21.91
Historical Range 18.31 - 24.1
Percentile 100.0%

Sector Context

Sector Average 57.32
Sector Median 35.38
Sector Rank #11 of 89
Sector Percentile 12.4%

Earnings Breakdown (TTM)

TTM EPS ₹31.41
Sept 2025 ₹8.82
Mar 2025 ₹7.80

Key P/E Ratio Insights for Acutaas Chemicals

  • Stock appears overvalued with PE of 88.56, suggesting caution for new investments
  • Current PE is 304.2% above historical average
  • Trading at premium to sector average PE of 57.32

View the ACUTAAS equity price for detailed stock performance.

P/E Ratio Historical Trend for Acutaas Chemicals

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 18.31 31.25 ₹572.20 NSE Moderate
2022 24.1 22.08 ₹532.10 NSE Moderate
2021 23.32 20.05 ₹467.50 NSE Moderate

Sector P/E Ratio Comparison

Comparing Acutaas Chemicals with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate